Menu
GeneBe

ING2

inhibitor of growth family member 2, the group of PHD finger proteins

Basic information

Region (hg38): 4:183505057-183512429

Previous symbols: [ "ING1L" ]

Links

ENSG00000168556NCBI:3622OMIM:604215HGNC:6063Uniprot:Q9H160AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ING2 gene.

  • Inborn genetic diseases (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ING2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 0

Variants in ING2

This is a list of pathogenic ClinVar variants found in the ING2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-183505211-C-A not specified Uncertain significance (Apr 27, 2023)2516669
4-183505308-T-C not specified Uncertain significance (Feb 13, 2023)2483081
4-183510545-G-A not specified Uncertain significance (Oct 20, 2023)3109654
4-183510591-G-A not specified Uncertain significance (Sep 15, 2021)2249395
4-183510761-A-G not specified Uncertain significance (Oct 26, 2022)2381632
4-183510906-T-C not specified Uncertain significance (Dec 27, 2022)2339253

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ING2protein_codingprotein_codingENST00000302327 26103
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7290.270125601011256020.00000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.74871460.5950.000007671833
Missense in Polyphen1652.0840.3072616
Synonymous0.4704852.30.9170.00000263485
Loss of Function2.83213.00.1546.48e-7166

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006210.0000621
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to be involved in p53/TP53 activation and p53/TP53-dependent apoptotic pathways, probably by enhancing acetylation of p53/TP53. Component of a mSin3A-like corepressor complex, which is probably involved in deacetylation of nucleosomal histones. ING2 activity seems to be modulated by binding to phosphoinositides (PtdInsPs). {ECO:0000269|PubMed:11481424, ECO:0000269|PubMed:12859901}.;
Pathway
Senescence and Autophagy in Cancer;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;PI5P Regulates TP53 Acetylation;TGF_beta_Receptor;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53 (Consensus)

Recessive Scores

pRec
0.130

Intolerance Scores

loftool
0.266
rvis_EVS
-0.1
rvis_percentile_EVS
46.2

Haploinsufficiency Scores

pHI
0.878
hipred
Y
hipred_score
0.764
ghis
0.591

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.876

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ing2
Phenotype
cellular phenotype; hematopoietic system phenotype; endocrine/exocrine gland phenotype; neoplasm; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;

Gene ontology

Biological process
chromatin organization;regulation of transcription, DNA-templated;male meiosis I;signal transduction;spermatogenesis;spermatid development;negative regulation of cell population proliferation;flagellated sperm motility;positive regulation of transforming growth factor beta receptor signaling pathway;positive regulation of histone deacetylation;regulation of growth;positive regulation of transcription, DNA-templated;male germ-line stem cell asymmetric division;seminiferous tubule development;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of cellular senescence;regulation of response to DNA damage stimulus
Cellular component
nucleus;nucleoplasm;Golgi apparatus;cytosol;plasma membrane;Sin3 complex;CCAAT-binding factor complex
Molecular function
DNA binding;chromatin binding;protein binding;methylated histone binding;phosphatidylinositol binding;protein-containing complex binding;metal ion binding